Long axial field of view (LAFOV) PET/CT is the latest development in PET instrumentation. This webinar will provide an overview of the clinical opportunities and applications of LAFOV PET in inflammation and infection imaging. Learning Objectives Target Audience Faculty Event Overview
This webinar aims to introduce the concept of theranostics and provide an overview of its potential. Participants will gain an understanding of how our technological competencies contribute to and enhance theranostic processes, and how we can leverage these strengths in practice. Please note that the webinar will be recorded, and the recording will be available […]
This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer, […]
more information coming soon Faculty Event Overview
This course presents and discusses the requirements and methods to enable and perform personalized dosimetry in nuclear medicine therapy. Learning Objectives The aim of this course is to provide tools and methods to implement personalized dosimetry in a clinical setup. Target Audience Nuclear medicine clinicians and medical physicists Suggested Readings "EANM enabling guide: how to […]
This webinar provides an overview of the diagnosis of cardiac amyloidosis in nuclear cardiology . Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. In this context, the relevance of quantification to […]
In nuclear medicine, diagnostic as well as therapeutic, radiopharmaceuticals are administered via an intravenous injection, in a majority of the procedures in a blood vessel at the crook of the arm or on the back of the hand. Occasionally, the injection fails, which results in the radiopharmaceutical ending up extravascularly. The consequence of this may […]
The purpose of this seminar is to provide a comprehensive overview of radionuclide therapy using alpha-emitting isotopes, focusing on their current clinical and preclinical applications. It will explore the unique advantages of alpha emitters, such as their high linear energy transfer and short path length, which allow for precise tumor cell killing with minimal damage […]
For performing the PET/CT examination, the administration of radiopharmaceutical as unavoidable for imaging with PET. Inversely, the administration of contrast agent to improve the quality of CT part of PET/CT as optional. The accurate intravenous administration of diagnostic radiopharmaceutical (and optionally of contrast agent) may be challenging in some cases, in particular in patients with […]
This webinar will emphasize the critical importance of radiation protection in safeguarding both the occupational health of care providers and the well-being of patients undergoing radionuclide therapy. It will underscore the necessity of adhering to established guidelines and protocols when handling radioactive materials to ensure safety and treatment efficacy. Furthermore, the session will explore the […]
The webinar will provide first the fundamentals and basics of explainable artificial intelligence, including the tools for interpretability of machine and deep learning models, as well as the explainability principles. Second, it will provide how these concepts are translated and applied to the development of AI-based models for nuclear medicine applications. Learning Objectives Target Audience […]
This ESMO 2025 webinar will cover a range of topics, including the latest advancements treatment options, imaging modalities and performant tracers related to solid and liquid tumors. The focus of this Live event will be the recent advances in solid & liquid tumor treatment, clinical trials and emerging therapies, biomarkers in solid tumors and multidisciplinary […]
